Aug. 4, 2025 — Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the second quarter ended June 30, 2025.
Summary results
|
Growth |
|||||||
|
Q2 2025 |
Q2 2024 |
Dollars |
Percent |
||||
|
(In Millions, Except Per Share Data) |
|||||||
|
Net operating revenue |
$ 1,457.7 |
$ 1,301.2 |
$ 156.5 |
12.0 % |
|||
|
Income from continuing operations attributable to |
1.40 |
1.13 |
0.27 |
23.9 % |
|||
|
Adjusted earnings per share |
1.40 |
1.11 |
0.29 |
26.1 % |
|||
|
Cash flows provided by operating activities |
270.2 |
217.4 |
52.8 |
24.3 % |
|||
|
Adjusted EBITDA |
318.6 |
271.8 |
46.8 |
17.2 % |
|||
|
Adjusted free cash flow |
185.9 |
142.5 |
43.4 |
30.5 % |
|||
|
(Actual Amounts) |
|||||||
|
Discharges |
65,237 |
60,833 |
7.2 % |
||||
|
Same-store discharge growth |
4.7 % |
||||||
|
Net patient revenue per discharge |
$ 21,670 |
$ 20,803 |
4.2 % |
||||
See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure.
- Revenue growth of 12.0% resulted from increased discharges and pricing. Total discharges grew 7.2%, inclusive of same-store growth of 4.7%. Net patient revenue per discharge grew 4.2%.
- Cash flows provided by operating activities increased 24.3% to $270.2 million, primarily due to an increase in net income.
- Adjusted EBITDA increased 17.2% from increased revenue and expense leverage.
“During the quarter, we further increased our capacity to serve patients in need of inpatient rehabilitation care, opening a new 60-bed hospital in Fort Myers, Florida, and adding 26 beds to an existing hospital,” said President and Chief Executive Officer Mark Tarr.
“Our clinical expertise and commitment to delivering high-quality, cost-effective care continues to benefit our patients, referral sources and payors.”
2025 Guidance
The Company increased its full-year guidance as follows:
|
Full-Year 2025 Guidance |
|||
|
Previous Guidance |
Updated Guidance |
||
|
(In Millions, Except Per Share Data) |
|||
|
Net operating revenue |
$5,850 to $5,925 |
$5,880 to $5,980 |
|
|
Adjusted EBITDA |
$1,185 to $1,220 |
$1,220 to $1,250 |
|
|
Adjusted earnings per share from continuing operations |
$4.85 to $5.10 |
$5.12 to $5.34 |
|
For considerations regarding the Company’s 2025 guidance, see the supplemental information posted on the Company’s website at http://investor.encompasshealth.com. See also the “Other information” section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.
Earnings conference call and webcast
The Company will host an investor conference call at 10:00 a.m. Eastern Time on Tuesday, August 5, 2025 to discuss its results for the second quarter of 2025. For reference during the call, the Company will post certain supplemental information at http://investor.encompasshealth.com.
The conference call may be accessed by dialing 800 343-4849 and giving the conference ID EHCQ225. International callers should dial 203 518-9848 and give the same conference ID. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available for on-line replay at http://investor.encompasshealth.com by clicking on an available link.
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 169 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune’s World’s Most Admired Companies™, and Forbes’ Most Trusted Companies in America.1 For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.
|
1 Fortune © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World’s Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. |